Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): A Review and the Caribbean Perspective | Zendy

Kimberly D. Mitchell | Zendy; Karen Guiuliana Lourenço | Zendy; E Guelmo-Daisley | Zendy; S. Romany | Zendy; Patrice Gill | Zendy; Fazarina Mohammed | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): A Review and the Caribbean Perspective

Author(s) -

Kimberly D. Mitchell,

Karen Guiuliana Lourenço,

E Guelmo-Daisley,

S. Romany,

Patrice Gill,

Fazarina Mohammed

Publication year - 2020

Publication title -

caribbean medical journal

Language(s) - English

Resource type - Journals

eISSN - 2664-5599

pISSN - 0374-7042

DOI - 10.48107/cmj.2020.12.010

Subject(s) - anaplastic large cell lymphoma , medicine , breast implant , anaplastic lymphoma kinase , implant , lymphoma , asymptomatic , large cell , surgery , oncology , cancer , adenocarcinoma , pleural effusion , malignant pleural effusion

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a rare CD-30 positive, Anaplastic Lymphoma Kinase Negative Non-Hodgkins lymphoma. The current estimated incidence is one to three cases per million implanted women. However, this is likely to rise with the increasing popularity of breast augmentation. This article contains a brief literature review and describes the Caribbean response to BIAALCL.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research